ΔNp53 or p44: Priming the p53 pump

International Journal of Biochemistry and Cell Biology

Volumn 37, Issue 5 SPEC. ISS., 2005, Pages 913-919

  Scrable, Heidi ^a   Sasaki, Tsutomu ^a,b   Maier, Bernhard ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Aging; Lifespan; Longevity gene; p47; p53 47; N isoform

Indexed keywords

AMINO ACID; GROWTH FACTOR; ISOPROTEIN; MESSENGER RNA; PROTEIN P44; PROTEIN P53; PROTEIN P63; PROTEIN P73; RNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR; HELICASE; MOUSE P47; P44 PROTEIN, MOUSE; PEPTIDE FRAGMENT;

AGING; EXON; GENE EXPRESSION; HUMAN; LIFESPAN; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CHEMISTRY; GENE DELETION; GENETICS; MOUSE; PROTEIN DENATURATION; TUMOR SUPPRESSOR GENE;

MAMMALIA; MURINAE;

AGING; ANIMALS; DNA HELICASES; GENES, P53; HUMANS; MICE; PEPTIDE FRAGMENTS; PROTEIN DENATURATION; PROTEIN ISOFORMS; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14644402379     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2004.11.014     Document Type: Short Survey

References (25)

1. J. Campisi Cancer and ageing: Rival demons? Nature Reviews. Cancer 3 2003 339 349
2. L.A. Cassiday, and L.J. Maher 3rd. Having it both ways: Transcription factors that bind DNA and RNA Nucleic Acids Research 30 2002 4118 4126
3. W.M. Chan, W.Y. Siu, A. Lau, and R.Y. Poon How many mutant p53 molecules are needed to inactivate a tetramer? Molecular and Cellular Biology 24 2004 3536 3551
4. E. Chu, C.H. Takimoto, D. Voeller, J.L. Grem, and C.J. Allegra Specific binding of human dihydrofolate reductase protein to dihydrofolate reductase messenger RNA in vitro Biochemistry 32 1993 4756 4760
5. S. Courtois, C.C. de Fromentel, and P. Hainaut p53 protein variants: Structural and functional similarities with p63 and p73 isoforms Oncogene 23 2004 631 638
6. S. Courtois, G. Verhaegh, S. North, M.G. Luciani, P. Lassus, and U. Hibner DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53 Oncogene 21 2002 6722 6728
7. P.K. Davis, and S.F. Dowdy p73 The International Journal of Biochemistry & Cell Biology 33 2001 935 939
8. J.V. Gannon, and D.P. Lane Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport Nature 349 1991 802 806
9. D. Gems, and L. Partridge Insulin/IGF signalling and ageing: Seeing the bigger picture Current Opinion in Genetics & Development 11 2001 287 292
10. A. Ghosh, D. Stewart, and G. Matlashewski Regulation of human p53 activity and cell localization by alternative splicing Molecular and Cellular Biology 24 2004 7987 7997
11. T. Inoue, R.K. Geyer, D. Howard, Z.K. Yu, and C.G. Maki MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding The Journal of Biological Chemistry 276 2001 45255 45260
12. A. Lavigueur, V. Maltby, D. Mock, J. Rossant, T. Pawson, and A. Bernstein High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene Molecular and Cellular Biology 9 1989 3982 3991
13. A. Li, and J.J. Blow The origin of CDK regulation Nature Cell Biology 3 2001 E182 E184
14. N.A. Little, and A.G. Jochemsen p63 The International Journal of Biochemistry and Cell Biology 34 2002 6 9
15. B. Maier, W. Gluba, B. Bernier, T. Turner, K. Mohammad, and T. Guise Modulation of mammalian life span by the short isoform of p53 Genes & Development 18 2004 306 319
16. G. Matlashewski, D. Pim, L. Banks, and L. Crawford Alternative splicing of human p53 transcripts Oncogene Research 1 1987 77 85
17. D. Michael, and M. Oren The p53-Mdm2 module and the ubiquitin system Seminars in Cancer Biology 13 2003 49 58
18. M. Mihara, S. Erster, A. Zaika, O. Petrenko, T. Chittenden, and P. Pancoska p53 has a direct apoptogenic role at the mitochondria Molecules and Cells 11 2003 577 590
19. R. Mokdad-Gargouri, K. Belhadj, and A. Gargouri Translational control of human p53 expression in yeast mediated by 5′-UTR-ORF structural interaction Nucleic Acids Research 29 2001 1222 1227
20. J. Mosner, T. Mummenbrauer, C. Bauer, G. Sczakiel, F. Grosse, and W. Deppert Negative feedback regulation of wild-type p53 biosynthesis The EMBO Journal 14 1995 4442 4449
21. M. Mowat, A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus Nature 314 1985 633 636
22. C.J. Sherr, and J.M. Roberts CDK inhibitors: Positive and negative regulators of G1-phase progression Genes & Development 13 1999 1501 1512
23. T. Unger, J.A. Mietz, M. Scheffner, C.L. Yee, and P.M. Howley Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression Molecular and Cellular Biology 13 1993 5186 5194
24. Y. Yin, C.W. Stephen, M.G. Luciani, and R. Fahraeus p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products Nature Cell Biology 4 2002 462 467
25. J. Zhu, W. Zhou, J. Jiang, and X. Chen Identification of a novel p53 functional domain that is necessary for mediating apoptosis The Journal of Biological Chemistry 273 1998 13030 13036